Author:
Renfro L.A.,Grothey A.,Kerr D.,Haller D.G.,André T.,Van Cutsem E.,Saltz L.,Labianca R.,Loprinzi C.L.,Alberts S.R.,Schmoll H.,Twelves C.,Yothers G.,Sargent D.J.,Sargent D.J.,Green E.,Grothey A.,Alberts S.R.,Shi Q.,Renfro L.A.,Yothers G.,O'Connell M.J.,Wolmark N.,de Gramont A.,Gray R.,Kerr D.,Haller D.G.,Guthrie K.,Buyse M.,Labianca R.,Seitz J.F.,O'Callaghan C.J.,Francini G.,Catalano P.J.,Blanke C.D.,Andre T.,Goldberg R.M.,Benson A.,Twelves C.,Sirzen F.,Cisar L.,Van Cutsem E.,Saltz L.
Funder
National Cancer Institute at the National Institutes of Health
Reference18 articles.
1. CDC – Colorectal Cancer Statistics. Centers for Disease Control and Prevention. Atlanta (GA). http://www.cdc.gov/cancer/colorectal/statistics/ (15 April 2014, date last accessed).
2. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004
3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009
4. Comparison of outcomes after 5-fulorouracil-based adjuvant therapy for stage II and III colon cancer between 1978–1995 and 1996–2007: evidence of stage migration from the ACCENT dataset;Shi;J Clin Oncol,2013
5. Evidence for cure by adjuvant chemotherapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials;Sargent;J Clin Oncol,2009
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献